Skip to content

Freenome

US · FRNM #2882 by market cap Listed 2024
16.03 -0.33 -2.02%
Live - 5344 symbols - heartbeat 375s ago · 2026-10-08 06:49
Pre-market 15.62 -2.56%
After-hours 16.03 0.00%
Market cap
1.72B
P/B
-1.24
EPS
-2.39
Reader sentiment Are you bullish or bearish on FRNM?

Anonymous reader poll. Unscientific, not investment advice.

Freenome last traded at 16.03, down 2.02% on the session. At current prices, the business is worth about 1.72B, the #2882 most valuable US-listed company we track. Wall Street's 4-analyst consensus lands on Buy, with a price target averaging 18.00 (+12% from here). The shares sit 81% of the way up their 52-week range of 9.95 to 17.50.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +45.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 1.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 977 U.S. stocks StockVane covers.

Overall B-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 93.6% Better than 99%
Operating margin -734.9% Better than 1%
Net margin -721.3% Better than 1%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 46.3% Better than 97%
6-month return 54.4% Better than 91%
12-month return (ex latest month) 53.9% Better than 82%
Distance below 52-week high 3.8% Better than 93%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 5.6x Better than 93%
Debt to assets 61.5% Better than 20%
Interest coverage -76.8x Better than 2%
Analyst View C+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 80%
Upside to average target 7.0% Better than 12%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.

Price chart

17.119.9916.032026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W +1.78%
1M -1.72%
3M +39.39%
6M +47.06%
YTD +23.02%
1Y +51.23%

Key statistics

Price & volume

Prev close
16.36
Open
16.20
Day range
15.80 - 16.62
Avg price
16.09
Volume
648.25K
Turnover
10.43M
Amplitude
5.01%
52-week range
9.95 - 17.50

Valuation

P/E
-6.71
P/E (TTM)
-6.71
P/B
-1.24
EPS
-2.39
Net profit
-256.80M
Net assets
-1.39B

Share structure

Market cap
1.72B
Float cap
798.04M
Shares out
107.45M
Float shares
49.78M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2024-06-12
52-week range 81% of range
9.95 17.50

8.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-7.97M net over the window

Short interest

Shares short
1.70M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Freenome (FRNM)?

Freenome last traded at 16.03. The quote on this page refreshes every few seconds while US markets are open.

What is Freenome's market cap?

About 1.72B.

What is the P/E ratio of Freenome?

The trailing twelve-month P/E is -6.71. The Valuation tab shows it against the stock's own five-year range.

Does Freenome pay a dividend?

Freenome does not currently pay a regular dividend.

Is Freenome a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 18.00, which implies 12.3% upside from the current price. This is not investment advice.

What is Freenome's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Freenome a B (Buy). Twelve-month momentum in the top 17% of the universe, above its 200-day average. Not investment advice.

Quote time 2026-10-08 06:49:02 · For reference only, not investment advice and not tailored to your situation.